Abbott Laboratories (ABT) is currently trading at $102.30. Based on 25 Wall Street analysts, the average target price is $132.28, implying a 29.3% upside. The consensus recommendation is BUY.
ABT
Abbott Laboratories
Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).
Price (USD)
Avg Target
$132.28
Based on 25 analysts
Analyst Recommendations
Upside
+29.31%
Market Cap
$177.76B
Financial & Investment Metrics
Latest News
Evercore ISI Adjusts Abbott Laboratories PT to $134 From $138, Maintains Outperform Rating
KBRA Assigns AAA Rating to Metropolitan Transit Authority of Harris County, TX Sales Tax Contractual Obligations Series 2026; Affirms Rating for Outstanding Bonds; Outlook Stable
EXCLUSIVE: Misty Copeland and Lana Condor Front Thorne’s New Women’s Health Campaign
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?
Insider Sentiment Index (Last 6 Months)
Buy vs Sell (Count)
Whale Trades (C-Level Large Buys)
No major insider buying detected recently.
Recent Insider Transactions
| Date | Name | Position | Transaction | Shares |
|---|---|---|---|---|
| 3/23/2026 | ORVILLE JACOB A | Officer | Stock Award(Grant) at price 0.00 per share. | 13,255 |
| 3/2/2026 | SALVADORI DANIEL GESUA SIVE | Officer | Sale at price 115.58 per share. | 885 |
| 3/2/2026 | MCCOY JOHN A. JR | Officer | Sale at price 115.58 per share. | 585 |
| 3/2/2026 | MORELAND MARY K | Officer | Sale at price 115.58 per share. | 613 |
| 3/2/2026 | MORRONE LOUIS H | Officer | Sale at price 115.58 per share. | 1,144 |
| 3/2/2026 | SHROFF ERIC | Officer | Sale at price 115.58 per share. | 709 |
| 3/2/2026 | CUSHMAN ELIZABETH C | General Counsel | Sale at price 115.58 per share. | 263 |
| 2/24/2026 | FORD ROBERT B. | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 83,464 |
| 2/24/2026 | SALVADORI DANIEL GESUA SIVE | Officer | Stock Award(Grant) at price 0.00 per share. | 21,644 |
| 2/24/2026 | SCOGGINS CHRISTOPHER J | Officer | Stock Award(Grant) at price 0.00 per share. | 18,502 |
Frequently Asked Questions
Q. What is the current target price and upside for ABT?
A. The current target price for Abbott Laboratories is $132.28, which implies a 29.3% upside from the current price of $102.30. This is based on the consensus of 25 Wall Street analysts.
Q. What is the current analyst recommendation for ABT?
A. Currently, there are 6 Strong Buy, 16 Buy, 7 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.
Q. Are insiders buying ABT stock recently?
A. Over the past 6 months, there have been 14 insider buys and 7 insider sells. This can be interpreted as a positive signal.